Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke.

Wang Y, Cooke MJ, Sachewsky N, Morshead CM, Shoichet MS.

J Control Release. 2013 Nov 28;172(1):1-11. doi: 10.1016/j.jconrel.2013.07.032. Epub 2013 Aug 9.

PMID:
23933523
2.

Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury.

Wang Y, Cooke MJ, Morshead CM, Shoichet MS.

Biomaterials. 2012 Mar;33(9):2681-92. doi: 10.1016/j.biomaterials.2011.12.031. Epub 2012 Jan 2.

PMID:
22217804
3.

Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain.

Cooke MJ, Wang Y, Morshead CM, Shoichet MS.

Biomaterials. 2011 Aug;32(24):5688-97. doi: 10.1016/j.biomaterials.2011.04.032. Epub 2011 May 7.

PMID:
21550655
4.

A hydrogel composite system for sustained epi-cortical delivery of Cyclosporin A to the brain for treatment of stroke.

Caicco MJ, Cooke MJ, Wang Y, Tuladhar A, Morshead CM, Shoichet MS.

J Control Release. 2013 Mar 28;166(3):197-202. doi: 10.1016/j.jconrel.2013.01.002. Epub 2013 Jan 8.

PMID:
23306024
5.

Circumventing the blood-brain barrier: Local delivery of cyclosporin A stimulates stem cells in stroke-injured rat brain.

Tuladhar A, Morshead CM, Shoichet MS.

J Control Release. 2015 Oct 10;215:1-11. doi: 10.1016/j.jconrel.2015.07.023. Epub 2015 Jul 27.

PMID:
26226344
6.

[Neuroprotector effect of human recombinant erythropoietin sorbed on polymer nanoparticles studied on model of intracerebral post-traumatic hematoma (hemorrhagic stroke)].

Balaban'ian VIu, Solev IN, Elizarova OS, Garibova TL, Litvinova SA, Voronina TA.

Eksp Klin Farmakol. 2011;74(10):17-22. Russian.

PMID:
22238981
7.

Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury.

Kang CE, Baumann MD, Tator CH, Shoichet MS.

Cells Tissues Organs. 2013;197(1):55-63. doi: 10.1159/000339589. Epub 2012 Jul 13.

PMID:
22796886
8.

Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.

Stanwick JC, Baumann MD, Shoichet MS.

J Control Release. 2012 Jun 28;160(3):666-75. doi: 10.1016/j.jconrel.2012.03.024. Epub 2012 Apr 4.

PMID:
22510446
9.

Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation.

Geng Y, Yuan W, Wu F, Chen J, He M, Jin T.

J Control Release. 2008 Sep 24;130(3):259-65. doi: 10.1016/j.jconrel.2008.06.011. Epub 2008 Jun 19.

PMID:
18620011
10.

A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair.

Kang CE, Poon PC, Tator CH, Shoichet MS.

Tissue Eng Part A. 2009 Mar;15(3):595-604. doi: 10.1089/ten.tea.2007.0349.

PMID:
18991489
11.

[Neuroprotective effect of recombinant human erythropoietin-loaded poly(lactic-co-glycolic) acid nanoparticles in rats with intracerebral posttraumatic hematoma].

Elizarova OS, Litvinova SA, Balaban'ian VIu, Barskov IV, Novikova SV, Stel'mashuk EV, Garibova TL, Voronina TA.

Eksp Klin Farmakol. 2012;75(8):7-10. Russian.

PMID:
23012988
12.

Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.

Kirby BP, Pabari R, Chen CN, Al Baharna M, Walsh J, Ramtoola Z.

J Pharm Pharmacol. 2013 Oct;65(10):1473-81. doi: 10.1111/jphp.12125. Epub 2013 Aug 1.

PMID:
24028614
13.

Controlled delivery of stromal derived factor-1α from poly lactic-co-glycolic acid core-shell particles to recruit mesenchymal stem cells for cardiac regeneration.

Zamani M, Prabhakaran MP, Thian ES, Ramakrishna S.

J Colloid Interface Sci. 2015 Aug 1;451:144-52. doi: 10.1016/j.jcis.2015.04.005. Epub 2015 Apr 6.

PMID:
25897850
14.

Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.

Hu Y, Hollinger JO, Marra KG.

J Drug Target. 2001;9(6):431-8.

PMID:
11822815
15.
16.

PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.

Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC.

Biomaterials. 2009 Mar;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013. Epub 2008 Dec 25.

PMID:
19111339
17.

Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia.

Simón-Yarza T, Tamayo E, Benavides C, Lana H, Formiga FR, Grama CN, Ortiz-de-Solorzano C, Kumar MN, Prosper F, Blanco-Prieto MJ.

Int J Pharm. 2013 Oct 1;454(2):784-90. doi: 10.1016/j.ijpharm.2013.04.015. Epub 2013 Apr 29.

PMID:
23639291
18.

Localized and sustained delivery of erythropoietin from PLGA microspheres promotes functional recovery and nerve regeneration in peripheral nerve injury.

Zhang W, Gao Y, Zhou Y, Liu J, Zhang L, Long A, Zhang L, Tang P.

Biomed Res Int. 2015;2015:478103. doi: 10.1155/2015/478103. Epub 2015 Mar 3. Erratum in: Biomed Res Int. 2015;2015:214703.

19.

Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release.

Goraltchouk A, Scanga V, Morshead CM, Shoichet MS.

J Control Release. 2006 Jan 10;110(2):400-7. Epub 2005 Dec 2.

PMID:
16325953
20.

Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury.

Tsurkan MV, Hauser PV, Zieris A, Carvalhosa R, Bussolati B, Freudenberg U, Camussi G, Werner C.

J Control Release. 2013 May 10;167(3):248-55. doi: 10.1016/j.jconrel.2013.01.030. Epub 2013 Feb 8.

Supplemental Content

Support Center